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Abstract
Background: Anogenital warts are the most easily recognized sign of genital Human Papilloma Virus
infection. The objective was to develop a short, valid and reliable questionnaire to measure Health Related
Quality of Life (HRQL) in patients with anogenital warts.
Methods: First a literature review was performed to identify relevant papers describing the impact of
anogenital warts in HRQL; second the main domains were identified by some experts in a focus group,
and third in-depth-semi-structured interviews were conducted in patients with anogenital warts to identify
the initial set of items. A qualitative reduction of the initial set of items was performed based on the mean
scoring of the experts for the three scales: clarity, frequency and importance. The initial questionnaire was
pilot tested in 135 patients. Rasch analysis was performed with the results of the questionnaire in order
to refine the instrument. Spearman's correlation was calculated between the initial questionnaire and the
reduced version. Additionally the measurement properties (validity and reliability) of the resulting final
questionnaire were tested and compared using standard procedures (Cronbach's Alpha and item-total
correlation).
Results: the main domains identified as affected in patient's life were: sexual, colleagues and partner
relationships. After a proper qualitative reduction the initial set of 134 items was reduced to 22. The
questionnaire was pilot tested in 135 patients and two dimensions were identified after the multifactorial
analysis: emotional dimension and sexual activity dimension. As a result of the Rasch analysis the
questionnaire was reduced to 10 items. High correlation was found between the initial and the reduced
version for the two dimensions. Cronbach's alpha values were acceptable (0.86).
Conclusion: The initial 22 items questionnaire was reduced by Rasch analysis to a version of 10 items,
with two dimensions: emotional and sexual. The results suggest the adequacy of the 10 items to evaluate
HRQL of patients with anogenital warts in a valid and reliable way.
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Background
Any health problem may place significant restrictions on
the normal development of physical, emotional and
social aspects of a patient's life. Health Related Quality of
Life (HRQL) is a multidimensional construct referring to
patient's perceptions of the impact of disease and treat-
ment on their physical, psychological, and social function
and well-being [1]. The increasing interest in measures
reflecting the personal viewpoint of patients' health has
led to an extended demand for reliable and valid stand-
ardized questionnaires of Health-Related Quality of Life
(HRQL) [2,3].
Although the use of HRQL questionnaires is more com-
mon in clinical research [4], their use in clinical practice
can also help clinicians to obtain standardized informa-
tion on the impact of the disease and its treatment on
patients' HRQL; information that cannot be obtained
using traditional measures, and that could be of a great
use in clinical decision making.
Taking into account features like item content, scope and
target population, instruments can be basically classified
as generic or disease-specific [5]. Disease-specific ques-
tionnaires, those that only contain items specifically
designed for a particular condition, are more likely to be
relevant and sensitive to patients in areas that clinicians
may wish to monitor [6,7].
Human Papilloma Virus (HPV) is one of the most com-
mon sexually transmitted infections. Its prevalence has
increased many fold throughout the world, and it is esti-
mated that a total of 1% of the sexually active population
are infected. One study in Korea showed that among sex-
ually active students, HPV prevalence was 38.8% in
females and 10.6% in males [8]. Another study in Hun-
gary showed an overall prevalence of HPV infection in
women of 23% [9]. The number of sexual partners, fre-
quency of sexual intercourse and the presence of genital
warts in the partner, have been identified as factors that
are related to HPV infection in women. In men only the
number of sexual intercourses have shown to be related to
the infection [10,11].
Genital warts (sometimes called condylomata acuminata
or venereal warts) are the most easily recognized sign of
genital HPV infection. Many people, however, have a gen-
ital HPV infection without genital warts. Genital warts are
soft, moist, or flesh colored and appear in the genital area
within weeks or months after infection. They sometimes
appear in clusters that resemble cauliflower-like bumps,
and are either raised or flat, small or large. Genital warts
can show up in women on the vulva and cervix, and inside
and surrounding the vagina and anus. In men, genital
warts can appear on the scrotum or penis.
Quality of life of patients with genital warts is potentially
affected [12]. Given the lack of a disease-specific instru-
ment to measure HRQL in patients with anogenital warts,
the objective of the study was to develop a short, valid and
reliable questionnaire to measure quality of life in
patients with anogenital warts.
Methods
The process of questionnaire elaboration was divided in
two phases:
• Phase I: Generation of quality of life issues (domains) and 
items
A qualitative study was performed to assess the quality of
life issues and to develop the items to be included in the
anogenital warts disease-specific questionnaire.
The strategy was to first carry out a literature review to
identify relevant papers describing the impact of anogeni-
tal warts in HRQL as well as to describe any question-
naires previously designed to measure HRQL in patients
with anogenital warts. A semi-structured questionnaire
was designed based on the results of the literature search.
Secondly, a group of experts answered the semi-structured
questionnaire in order to identify those domains of ano-
genital warts they believed would cause problems in
patients' life. Afterwards a focus group was organized with
the same ten experts. The moderator of the focus group
was responsible for leading the discussion among experts
in order to reach a final consensus about the dimensions
to be considered in the final questionnaire.
• Phase II
This was divided in the following steps:
1. Identification of the initial set of items through semi-
structured interviews to a sample of patients.
2. Qualitative reduction of the initial set of items
3. Questionnaire design
4. Administration of the questionnaire to a sample of
patients
5. Quantitative reduction of items, Rasch analysis.
1. Identification of the initial set of items through semi-structured 
interview
With the aim of evaluating the impact of the symptoms of
genital warts and its treatment in the quality of life, a
group of patients were interviewed, using in-depth semi-
structured-questionnaires. The interviewer made sure that
the patient took into account all the dimensions previ-
ously identified by the experts and also tried to identifyHealth and Quality of Life Outcomes 2005, 3:24 http://www.hqlo.com/content/3/1/24
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new dimensions that could arise during the interview. The
interview focused on the impact of the disease on the
physical, psychological and social functioning of the
patient.
All semi-structured interviews were tape-recorded and
transcribed to paper for the qualitative content analysis. A
first qualitative analysis was based on the redundancy and
repetition of expressions. As a result a first set of items was
obtained.
2. Qualitative reduction of the initial set of items
In a second meeting, the experts scored each one of the
items. The criteria to include or exclude each one of the
134 items analyzed were based on the mean scoring given
by the experts for the three scales: "clarity of wording",
"frequency of occurrence", and "importance" among
patients with anogenital warts, using a 1–5 Likert-type
scale. Items were considered for final inclusion if clarity,
frequency and importance were considered high, if clarity
and importance were high together with low frequency,
and also if frequency and importance were high and clar-
ity low; in this latter situation the item was included but
modified to enhance clarity. Low values were defined as
those ones below percentile 50 of the distribution of the
three scales, and high values where those ones above per-
centile 50. Based on the results of the scoring of each item
a first item reduction was obtained.
3. Questionnaire design and administration to a sample of patients
The pre- identified items were put together in a question-
naire format. The questionnaire was administered to a
sample patients with anogenital warts.
4. Quantitative reduction of the items
A multifactorial analysis was performed to define possible
dimensions within the questionnaire. In order to refine
the instrument a further quantitative reduction was per-
formed with Rasch analysis (dichotomous logistic
response model) [13], using the answers to the question-
naire from a group of patients with anogenital warts. The
Rasch model constructs a line of measurement with the
items placed hierarchically and provides fit statistics to
indicate just how well different items describe the group
of subjects responding to a questionnaire [14]. In this
study a Infit and Outfit value below 1.3 was accepted. No
definitive rules exist regarding what is considered accepta-
ble and unacceptable fit, but values greater than 1.3, in a
sample smaller than 500, are usually diagnosed as poten-
tial misfits to Rasch model condition [15].
A Spearman's correlation was obtained between the origi-
nal questionnaire and the final reduced version. Addition-
ally the measurement properties (validity and reliability)
of the resulting final questionnaire were tested and com-
pared using standard procedures (Cronbach's Alpha and
item-total correlation).
Results and Discussion
This study attempts to develop a disease-specific quality-
of-life questionnaire for adults with anogenital warts. The
fact that is a disease specific one allows the comparison
between groups of patients within the same disease.
Phase I: Generation of quality of life domains and items
Pubmed data base was searched [16]. No specific instru-
ment to measure HRQL in patients with anogenital warts
was found after the literature review. Only a few studies
were found that had considered which dimensions of
HRQL were affected in patients with anogenital warts.
Based on the results of the literature research a semi-struc-
tured questionnaire was elaborated.
Three dermatologists and one gynaecologist answered the
semi-structured questionnaire, as well as two experts in
the elaboration of HRQL instruments. Given that ano-
genital warts are mainly seen by dermatologists and
gynaecologists in Spain, these two specializations were
chosen in order to get the widest perspective of the popu-
lation affected with anogenital warts and the aspects that
impact their quality of life. Three aspects were identified
as having impact on HRQL of patients with anogenital
warts: sexual relationships, relationships with colleagues,
and within the couple relationship. The aspects that worry
the patient mentioned by the participants were: conta-
gion, cancer, guilt, anticonceptive methods, pregnancy,
infidelity and low performance. In men the most affected
aspects were sexual relationships (continuity of sexual
relationships, fear to contagion and use of condom). In
women the most affected aspects were maternity (fear to
pregnancy and possibility to contagion for the baby), fear
to cancer, sexual relationships and within couple
relationship.
Finally all participants agreed that the aspects that most
impact HRQL of patients with anogenital warts are: cou-
ple relationship, guilt, and fear of contagion. It is worth
pointing out that at this initial state none of the experts
mentioned the patient's worry about the effectiveness of
the treatment, while all the aspects were more related to
patient's relationships.
With all the information gathered in phase I a guideline
for the semi-structured interview of patients was
elaborated.
Phase II
Identification of the initial set of items
A total of 20 in-depth semi-structured interviews of
patients with anogenital warts were obtained betweenHealth and Quality of Life Outcomes 2005, 3:24 http://www.hqlo.com/content/3/1/24
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June and July 2003. The sample of 20 patients is consid-
ered to be more than enough in qualitative research at the
stage of identifying dimensions [17]. The participants
were 11 men and 9 women, mean age 34.2, ranging from
19 to 53. Mean time since diagnosis was 25.3 months,
ranging from 15 years (1 patient) to 1 month (2 patients).
The treatment received by the patients was: criotherapy in
9 cases, inmunomodulators in 2 cases, and no treatment
in 9 cases. The interviews were conducted by two experi-
enced psychologists.
The focus group technique could have also been used in
this step. The advantages of focus group is that they do not
discriminate against patients who cannot read or write
and they can encounter participation from people reluc-
tant to be interviewed. [18]. In this case a semi-structured
interviewed was chosen because the initial domains were
already identified, therefore the semi-structured inter-
viewed was good to provide information on concrete
issues allowing open answers.
The dimensions identified were: physical, psychological,
social, sexual, everyday life activities, symptoms, percep-
tion of the disease, perception of health and perception of
treatment. After the qualitative analysis, based on the
redundancy and repetition of expressions, a first set of 134
items was obtained.
The selection of items was based on patient's opinion and
health professional's views. The aim of this methodologi-
cal approach is to ensure that the content and validity
(specificity and sensibility) of the tool under construction
is appropriate for the target population. In other words,
whether the questionnaire deals with relevant questions
on disease and treatment and does not omit important
patient issues [19]. As we see in this study, treatment
issues were not initially mentioned by experts while the
issue was raised by the patients later on.
Regarding the patient issues the results do not differ from
the ones found in the literature. In a survey by the Ameri-
can Social Health Association among people with human
papillomavirus infection, more than three-quarters of
respondents reported feelings of depression and anger,
and two-thirds feelings of shame. Sexual enjoyment and
sexual activity were also negatively affected by genital
warts [20]. Other studies have shown a negative impact in
the social life of the patient [12].
It has been demonstrated that the help seeking behaviour
in patients with sexually transmitted diseases is deter-
Table 1: Results of the administration of the 22 item questionnaire to a sample of patients. The items of the final 10-item questionnaire 
are highlighted in bold
N° of Item Item n Range Mean scoring (SD)
Min Max
1 The discomfort that they cause me affects my daily activites. 135 1 5 3.5 (1.2)
2 I worry too much about my personal hygiene 135 1 5 1.7 (0.9)
3 I am afraid that the lesions won't disappear 135 1 5 2.4 (1.4)
4 I am anxious to know whether I am going to recover from the infection for good 134 1 5 1.7 (1.1)
5 I worry about whether the warts will get worse or if there will be some 
complications
135 1 5 2.1 (1.3)
6 I have feelings of guilt 135 1 5 3.3 (1.4)
7 I am anxious to know who infected me and when 135 1 5 2.2 (1.4)
8 I worry that I might infect other people 135 1 5 1.4 (0.8)
9 My state of mind is upset (anxiety, depression, sadness, uneasiness...) 135 1 5 2.9 (1.2)
10 I feel more insecure 135 1 5 2.9 (1.3)
11 Knowing that I have the illness affects me in my daily life 135 1 5 3.3 (1.3)
12 I worry about whether I might have problems in having children in the future 135 1 5 3.7 (1.5)
13 I worry about the lack of knowledge concerning my illness and its treatment 135 1 5 2.7 (1.5)
14 I worry about people finding out about my illness (at work, at leisure centres, etc.) 135 1 5 2.4 (1.6)
15 My personal relationships have been affected (partner, friendship, 134 1 5 3.1 (1.4)
16 My sexual drive has decreased 135 1 5 3.4 (1.4)
17 I feel worried during the act 135 1 5 2.8 (1.4)
18 I avoid sexual relations 134 1 5 3.3 (1.4)
19 My sexual relations have decreased in quality and/or frequency 135 1 5 3.0 (1.4)
20 I worry about having to use barrier methods (condom, diaphragm) to have sexual relation 135 1 5 3.5 (1.6)
21 The discomfort produced by treatment affects my daily life 135 1 5 3.7 (1.3)
22 I worry about having to follow a treatment for a long time 135 1 5 2.4 (1.4)Health and Quality of Life Outcomes 2005, 3:24 http://www.hqlo.com/content/3/1/24
Page 5 of 7
(page number not for citation purposes)
mined by the shame and stigma that they feel [21-23].
This fact might limit the results of the study because those
patients who did not seek for health care due to shame
and stigma were not able to participate in the study.
Qualitative reduction of the initial set of items
The criteria to include or exclude each one of the 134
items analyzed were based on the mean scoring given by
the experts for the three scales: "clarity of wording", "fre-
quency of occurrence", and "importance". A total of 49
items were included.
A further qualitative review of the pre-selected items based
on prior experience with other similar instruments con-
cluded in the initial 22 -item questionnaire, which was
called CECA 22 (Cuestionario Específico en Condilomas
Acuminados, in Spanish) (Table 1). The questions
referred to the previous 7 days before the visit, and each
question allowed an answer in a 5 options Likert scale
(always, almost always, sometimes, rarely, never) with the
exception of items 3, 5, and 21 that also allowed the
option of "not applicable". The higher the score the better
the quality of life.
Administration of the questionnaire to a sample of patients
The 22 item questionnaire was pilot tested in a sample of
135 patients diagnosed of anogenital warts from different
centers throughout Spain. Mean age (SD) was 31.1 (7.3),
51% of them were women. A total of 76.3% of the
patients were heterosexual and 17.8% homosexual. In
32.1% of the patients the anogenital warts were not visi-
ble at the moment of the visit. In 6% the extension of the
wart was large (>200 mm2), in 29.6% was medium (50–
200 mm2) and small in 35.1% (< 50 mm2). The anogeni-
tal warts were mostly located in the penis in men and
vulva in women. The diversity of the patients' disease sit-
uation enhanced the possibility of getting as many broad
results as possible.
The questionnaire was completely fulfilled by the 132
patients (response rate 132/135). The results of the
administration are shown in table 1. Sexual activities and
everyday life activities, as well the worry for having chil-
dren were the dimensions that obtained higher scoring,
meaning that they were the main worry for the patient.
Quantitative reduction of the items
The multifactorial analysis identified two possible dimen-
sions in the preliminary CECA questionnaire. The first
one (emotional dimension) was integrated by the first 15
items, and the second (sexual activity dimension) was
integrated by the 7 remaining items. Afterwards the Rasch
analysis was performed for each one of the dimensions.
Rasch model enumerates the items in relation to gravity
and selects the items according to: adjustment to the
model, redundancy, discriminant validity, and content.
As a result of it, the first dimension initially formed by 15
items was reduced to a total of 6 items including: item 3,
4, 5, 9, 10 and 11. There was evidence of the overlapping
of item 9 and 10 but the decision of excluding or keeping
any of them was totally qualitative. The final decision was
to keep the six items. The second dimension (7 items) was
reduced to 4 items, including : item 16, 17, 18 and 19.
Therefore the final version of the questionnaire had a total
of 10 items (Table 1). Global scoring range was 10 to 50,
going from 6 to 30 in the emotional dimension and from
4 to 20 in sexual activity dimension. All dimensions were
standardized for a scoring between 0 (worst HRQL) and
100 (the best HRQL) in order to facilitate the interpreta-
tion and comprehension.
Afterwards a global final analysis was performed to evalu-
ate the adequacy of the total of the selected items in the
final reduced version. The correlation between the
reduced version and the two dimensions (emotional and
sexual activity) in the 22 item questionnaire was high
(Table 2). The results of the item-total correlation and the
Table 2: Correlation between the reduced version and the two dimensions (emotional and sexual activity) in the 22 item 
questionnaire
CECA10 CECA6 (emotional) CECA4 (sexual activity)
CECA6 (emotional) r = 0.851*
n = 133
CECA4 (sexual activity) r = 0.830*
n = 133
r = 0.433*
n = 133
CECA22 r = 0.928*
n = 133
r = 0.845*
n = 132
r = 0.719*
n = 132
* p < 0.01
CECA 22: initial 22-item questionnaire
CECA 10: 10-item questionnaire
CECA 6: emotional dimension in the 10-items questionnaire
CECA 4 sexual activity dimension in the 4-item questionnaireHealth and Quality of Life Outcomes 2005, 3:24 http://www.hqlo.com/content/3/1/24
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reliability (Cronbach's alpha) for the reduced version as
well as for the initial 22-items one are shown in table 3.
Item total correlation is the correlation coefficient
between the score on an individual item and the total
score for the whole set of items of which the individual
item is a part. It provides a clue of the internal consistency,
the higher the value the higher the consistency (minimum
recommended value 0.3).
The mean (SD) scoring for CECA-10, in a 0 to 100 scale,
was 44,6 (Table 4). The CECA-6 factor showed a mean
(SD) of 38,8 (23.9) and the factor CECA-4 53.4 (29.3).
Patients showed worse quality of life (more impact) in the
emotional dimension.
Even though the final questionnaire was initially designed
to be equally valid for both genders, it would be interest-
ing in future research to develop gender specific question-
naires given the characteristics of the disease.
Conclusion
The original CECA questionnaire composed by 22 items
was reduced by Rasch analysis to a version of 10 items.
Two dimensions were identified in the final question-
naire: emotional and sexual activity. The results suggest
the adequacy of the 10 items to evaluate in a valid and
reliable way the HRQL of patients with anogenital warts.
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